1 - 25 of 1
Number of results to display per page
TitleCreatorDescriptionIdentifier
1 Baseline OCT Findings in Phase 3 RESCUE and REVERSE TrialsRobert Sergott, Barrett KatzrAAV2/2-ND4 is an investigational gene therapy facilitating allotopic transgene expression. We report baseline spectral domain OCT of the RNFL and GCL in two Phase 3 trials.20180306_nanos_posters_170
1 - 25 of 1